These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 2033190
21. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. Buxton AE, Josephson ME, Marchlinski FE, Miller JM. J Am Coll Cardiol; 1993 Jan; 21(1):90-8. PubMed ID: 8417082 [Abstract] [Full Text] [Related]
22. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Miura DS, Wynn J, Torres V, Laux B, Keefe D, Somberg JC. Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503 [Abstract] [Full Text] [Related]
23. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction. Karagueuzian HS, Ohta M, Drury JK, Fishbein MC, Meerbaum S, Corday E, Mandel WJ, Peter T. J Am Coll Cardiol; 1986 Mar; 7(3):551-63. PubMed ID: 3950235 [Abstract] [Full Text] [Related]
24. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia. Somberg J, Wynn J, Miura D, Torres V, Williams S, Keefe D. Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972 [Abstract] [Full Text] [Related]
25. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, Josephson ME. Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163 [Abstract] [Full Text] [Related]
26. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia. Grimm W, Cho JG, Marchlinski FE. J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707 [Abstract] [Full Text] [Related]
27. A comparison of sotalol and procainamide in symptomatic ventricular tachycardia. Jordaens LJ, Colardyn F, Clement DL. Cardiovasc Drugs Ther; 1989 Apr; 3(2):155-61. PubMed ID: 2487531 [Abstract] [Full Text] [Related]
28. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia. Dorian P, Newman D, Berman N, Hardy J, Mitchell J. J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529 [Abstract] [Full Text] [Related]
29. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. Buxton AE, Rosenthal ME, Marchlinski FE, Miller JM, Flores B, Josephson ME. Am J Cardiol; 1991 Apr 15; 67(9):835-42. PubMed ID: 1707220 [Abstract] [Full Text] [Related]
30. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Wynn J, Miura DS, Torres V, Flowers D, Keefe D, Williams S, Somberg JC. Am J Cardiol; 1985 Nov 15; 56(13):877-81. PubMed ID: 2414983 [Abstract] [Full Text] [Related]
31. Intravenous Procainamide for Predicting the Response of Sustained Ventricular Tachycardia to Type III Antiarrhythmic Drugs. Snow JS, Cohen MB, Jadonath RL, Cohen TJ. J Invasive Cardiol; 1997 Jan 15; 9(1):40-44. PubMed ID: 10762873 [Abstract] [Full Text] [Related]
32. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Circulation; 1978 Dec 15; 58(6):986-97. PubMed ID: 709782 [Abstract] [Full Text] [Related]
39. Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group. Singh BN, Kehoe R, Woosley RL, Scheinman M, Quart B. Am Heart J; 1995 Jan 15; 129(1):87-97. PubMed ID: 7817931 [Abstract] [Full Text] [Related]